US FDA's Spikevax Review By The Numbers

 
• By Sue Sutter

A timeline of the development and approval of Moderna's mRNA vaccine, and a listing of FDA reviewers on the biologics license application.

Drug Review Profile: Spikevax Chronology
Moderna's COVID-19 vaccine moved from pre-IND meeting to full approval in less than two years. • Source: Alamy

More from Drug Review Profiles

More from Product Reviews